BioCryst Pharmaceuticals, Inc

BCRX NASDAQ
BCRX
BioCryst Pharmaceuticals, Inc NASDAQ
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

BCRX financial statements

The current financial position of BioCryst Pharmaceuticals, Inc

Total assets of BCRX for Q1 22 is 527.72M USD, 10.27% less than the previous Q4 21. And total liabilities decreased by 0.46% in Q1 22 to 691.93M USD.

Total assets
Total current assets
Total non-current assets
Total liabilities
Total current liabilities
Total non-current liabilities
Total equity
Total liabilities & shareholders' equities
Total debt
Net debt
Book value per share